Business

The Caris Precision Oncology Alliance Welcomes UAMS Winthrop P. Rockefeller Cancer Institute

IRVING, Texas, Dec. 2, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision

articleCaris Life Sciences, Inc.December 2, 20254/company/caris-life-sciences-inc-common-stock/news/caris-precision-oncology-alliance-welcomes-uams-winthrop-p-rockefeller-cancer
The Caris Precision Oncology Alliance Welcomes UAMS Winthrop P. Rockefeller Cancer Institute

About this update from Caris Life Sciences, Inc.

[{"type":"text","content":"IRVING, Texas, Dec. 2, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute has joined the Caris Precision Oncology Alliance™ (Caris POA). The Caris POA is a global network of top cancer centers and research groups that work together to advance precision oncology and biomarker-driven research.\n \n \n \n \n \n \n \n\"It is great to welcome UAMS to the Caris POA. Their unwavering commitment to excellence perfectly aligns with our commitment to advance biomarker-driven precision oncology,\" said James Hamrick, MD, MPH, Chairman of the Caris POA. \"Together, we will leverage shared data and cutting-edge AI to accelerate research and translate it into personalized care for patients in Arkansas and around the world.\" Caris POA members establish and refine molecular testing standards through collaborative research designed to improve clinical outcomes for cancer patients. By harnessing Caris' advanced AI-driven bioinformatics and machine learning platform and a vast multi-modal database, the Caris POA accelerates discovery and translates innovative findings into more effective, personalized patient care.The Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences is a cancer research and treatment center located in Little Rock, Arkansas. Supported by nationally recognized physicians, scientists and cancer experts offering comprehensive, research-driven care for patients across the nation with the most common to the rarest and most complex diseases. \"Joining the Caris Precision Oncology Alliance strengthens our ability to bring the most advanced, data-driven cancer care to patients in Arkansas and beyond,\" said Michael Birrer, M.D., Ph.D., director of the UAMS Winthrop P. Rockefeller Cancer Institute. \"This collaboration allows us to contribute to, and benefit from, a global network of leading institutions using precision medicine to accelerate discoveries and deliver truly personalized cancer treatment.\"With the newest addition, the Caris POA now comprises 98 cancer centers, academic institutions, research consortia, and healthcare systems, including 45 NCI-designated cancer centers,...

More updates from Caris Life Sciences, Inc.